As India grapples with a growing burden of diabetes and lifestyle-related disorders, attention has turned to Ozempic, a ...
Asian News International on MSN
Novo Nordisk launches Ozempic in India for diabetes, weight management at ₹2,200/week
New Delhi, 13 Dec 2025 (ANI): Novo Nordisk launches Ozempic in India for diabetes, weight management at ₹2,200/week ...
“Sensitive to Indian socioeconomic class”, Novo Nordisk MD on introducing Ozempic at ₹2,200 per week ...
Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting approval to Novo Nordisk India for its proposed update to ...
But even as Ozempic enters India, there is a growing sense globally that Novo may have already lost the obesity drug war to Mounjaro, Eli Lilly’s blockbuster that has become India’s top-selling drug ...
Recent clinical trials of Novo Nordisk’s blockbuster GLP-1 drug semaglutide for Alzheimer’s disease may have failed to show ...
Chennai, Dec. 13 -- Highlights: ...
YOU may be keen to shed pounds from your waistline with fat jabs, but forking out the monthly bill is less appealing – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback